| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008486A1 Avirulent microbes and uses therefor: salmonella typhi |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992007063A3 A culture device having a detachable cell or tissue growth surface |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487301A1 Method of stabilizing enzyme conjugates |
| 05/27/1992 | EP0487298A2 Human gamma interferon antagonist/agonist screen |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486619A1 Method of screening for protein inhibitors and activators |
| 05/27/1992 | EP0486585A1 Nucleation of ice |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | EP0391936B1 Device for culturing cells immobilized in a bioreactor |
| 05/27/1992 | EP0379554A4 Human immune system in non-human animal |
| 05/27/1992 | CN1016795B Production of hemopoietin |
| 05/26/1992 | US5116964 Hybrid immunoglobulins |
| 05/26/1992 | US5116753 Maintenance of pancreatic islets |
| 05/26/1992 | US5116747 Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate |
| 05/26/1992 | US5116724 Products for separation applicable to cells in the immunopurification field |
| 05/26/1992 | US5116368 Polypeptides with fibronectin activity |
| 05/26/1992 | CA1301677C Recombinant surface antigens of swine mycoplasma and vaccines and diagnostics based on them |
| 05/26/1992 | CA1301675C Polycistronic expression vector construction |
| 05/21/1992 | CA2055812A1 Method of stabilizing enzyme conjugates |
| 05/20/1992 | WO1992008985A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/20/1992 | EP0486234A2 Plant transformation method using agrobacterium species |
| 05/20/1992 | EP0486233A2 Plant transformation method using agrobacterium species |
| 05/20/1992 | EP0486214A2 Putrescine N-methyltransferase, recombinant DNA molecules encoding putrescine N-methyltrasferase, and transgenic tobacco plants with altered nicotine content |
| 05/20/1992 | EP0486193A2 A method for altering post-translational processing of tissue plasminogen activator |
| 05/20/1992 | EP0486106A2 Marek's disease virus vaccine |
| 05/20/1992 | EP0485689A1 Cells growing in protein-free medium, and enhancing replication of exogenous genes |
| 05/20/1992 | EP0485532A1 Fucosyl transferases involved in adhesion molecule expression |
| 05/20/1992 | EP0485506A1 Methods and compositions for the production of stably transformed, fertile maize plants and cells thereof |
| 05/20/1992 | EP0485504A1 Cell culture methods for producing activated protein c. |
| 05/20/1992 | EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 05/20/1992 | EP0485407A1 Proteins with tnf activity |
| 05/20/1992 | EP0465572A4 Genetic engineering of novel plant phenotypes |
| 05/20/1992 | EP0460057A4 Method and medium for packaging entomogenous nematodes |
| 05/19/1992 | US5114855 Suspension |
| 05/19/1992 | US5114854 Catheters for puncturing cells |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114842 Immunology, DNA and DNA sequences encoding genes |
| 05/19/1992 | US5114413 Methods to make and use proteinaceous material present in kinin-free high molecular weight kininogen |
| 05/19/1992 | CA1301095C Human che type proteins and their production |
| 05/15/1992 | CA2095539A1 Diagnosis and treatment of multiple sclerosis |
| 05/14/1992 | WO1992008796A1 Bifunctional selectable fusion genes |
| 05/14/1992 | WO1992008131A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007942A1 Polypeptides involved in the expression of resistance to glycopeptidic antibiotics |
| 05/14/1992 | WO1992007938A1 Cell growth inhibitors |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | WO1991018984A3 New antifungal preparations, process for making such preparations, process for obtaining plants with decreased susceptibility to fungi |
| 05/14/1992 | WO1991002071A3 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2094378A1 Development of dna probes and immunological reagents of human tumor associated antigens |
| 05/13/1992 | EP0485044A2 Plasmids for the production of transgenic plants that are modified in habit and yield |
| 05/13/1992 | EP0484863A1 A monoclonal antibody and a method for measuring malondialdehyde-reacted low-density-lipoproteins |
| 05/13/1992 | EP0484452A1 Fibulin |
| 05/13/1992 | EP0484440A1 Efficient directional genetic cloning system |
| 05/13/1992 | EP0484396A1 Avipox virus promoters |
| 05/13/1992 | EP0484380A1 Uses of interleukin-4 and method for purifying it |
| 05/13/1992 | EP0448650A4 Herpes simplex virus type i expression vector |
| 05/13/1992 | EP0260280B1 Immunoselection method |
| 05/13/1992 | CN1016574B Pollen-mediated plant transformation |
| 05/12/1992 | US5112948 Methods and compositions for inducing monocyte cytotoxicity |
| 05/12/1992 | US5112760 Mass transfer membrane for oxygenation of animal cell reactors |
| 05/12/1992 | US5112757 Method for obtaining human hepatocyte cultures |
| 05/12/1992 | US5112748 Hybrid cells producing an antigen characteristic of the hepatitis b virus obtained from hepatocytes and established monkey cells, a process for obtaining these hybrid cells and their application to the production of the aforesaid antigen |
| 05/12/1992 | US5112737 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 05/12/1992 | US5112606 Method of producing antibodies using colloidal metal as carrier |
| 05/12/1992 | CA1300506C Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | WO1992008793A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/10/1992 | WO1992008495A1 Cytokine immunoconjugates |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2095635A1 Chinese hamster ovary cell retrovirus-like c particles |
| 05/09/1992 | CA2055150A1 Plasmids for the production of transgenic plants that are modified in habit and yield |
| 05/07/1992 | CA2095428A1 Test for virulent revertants in attenuated live vaccines |
| 05/07/1992 | CA2054791A1 Method for altering post-translational processing of tissue plasminogen activator |
| 05/06/1992 | EP0483847A2 Method for preparing transformed plant |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483247A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 05/06/1992 | EP0483219A1 Enhancement of musculature in animals |
| 05/06/1992 | EP0461180A4 Development of a monoclonal antibody based detection system for listeria monocytogenes |
| 05/06/1992 | CN1060871A Novel onco-fetal gene, gene product and uses therefor |
| 05/06/1992 | CN1016515B Method for culturing plant tissue |
| 05/05/1992 | US5110906 Derivatives of soluble T-4 |
| 05/05/1992 | US5110738 Genetic engineering; hybridomas of melanoma and spleen cells |
| 05/05/1992 | US5110737 Culture in cholesterol-free medium |
| 05/05/1992 | CA1300058C Process for preparing activated killer cells |
| 05/05/1992 | CA1300052C Episomal vector for the expression of selected dna fragments coding for optional polypeptides in mammalian cells and methods for the production thereof |
| 05/03/1992 | WO1992007460A1 Formulations of plant culture media and applications therefor |
| 05/03/1992 | CA2095328A1 Formulations of plant culture media and applications therefor |
| 05/01/1992 | WO1992008731A2 T-cadherin adhesion molecule |
| 05/01/1992 | CA2095115A1 T-cadherin adhesion molecule |